company background image
301065 logo

Zhejiang Benli Technology SZSE:301065 Stock Report

Last Price

CN¥18.52

Market Cap

CN¥1.9b

7D

13.2%

1Y

-12.8%

Updated

06 Aug, 2024

Data

Company Financials

Zhejiang Benli Technology Co., Ltd.

SZSE:301065 Stock Report

Market Cap: CN¥1.9b

301065 Stock Overview

Engages in the research, development, production, and sale of pharmaceutical, pesticide, and other material intermediates in China and internationally.

301065 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends2/6

Zhejiang Benli Technology Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Zhejiang Benli Technology
Historical stock prices
Current Share PriceCN¥18.52
52 Week HighCN¥24.84
52 Week LowCN¥11.81
Beta-0.0072
11 Month Change15.32%
3 Month Change-7.54%
1 Year Change-12.81%
33 Year Changen/a
5 Year Changen/a
Change since IPO-64.55%

Recent News & Updates

Recent updates

Zhejiang Benli Technology (SZSE:301065) Will Pay A Smaller Dividend Than Last Year

Jun 19
Zhejiang Benli Technology (SZSE:301065) Will Pay A Smaller Dividend Than Last Year

Lacklustre Performance Is Driving Zhejiang Benli Technology Co., Ltd.'s (SZSE:301065) Low P/E

Jun 07
Lacklustre Performance Is Driving Zhejiang Benli Technology Co., Ltd.'s (SZSE:301065) Low P/E

We Think You Should Be Aware Of Some Concerning Factors In Zhejiang Benli Technology's (SZSE:301065) Earnings

May 02
We Think You Should Be Aware Of Some Concerning Factors In Zhejiang Benli Technology's (SZSE:301065) Earnings

Earnings Not Telling The Story For Zhejiang Benli Technology Co., Ltd. (SZSE:301065) After Shares Rise 30%

Mar 08
Earnings Not Telling The Story For Zhejiang Benli Technology Co., Ltd. (SZSE:301065) After Shares Rise 30%

Shareholder Returns

301065CN PharmaceuticalsCN Market
7D13.2%6.4%0.4%
1Y-12.8%-10.6%-21.0%

Return vs Industry: 301065 underperformed the CN Pharmaceuticals industry which returned -10.6% over the past year.

Return vs Market: 301065 exceeded the CN Market which returned -22% over the past year.

Price Volatility

Is 301065's price volatile compared to industry and market?
301065 volatility
301065 Average Weekly Movement6.3%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement5.7%
10% most volatile stocks in CN Market9.0%
10% least volatile stocks in CN Market3.8%

Stable Share Price: 301065 has not had significant price volatility in the past 3 months.

Volatility Over Time: 301065's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011589Zhengjie Wuwww.benlitech.com

Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sale of pharmaceutical, pesticide, and other material intermediates in China and internationally. Its products include N,N-Dimethylamino ethyl acrylate; 2,4-Dichloro-5-fluorobenzoyl chloride; 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamino acrylate ethyl ester; 1-Ethyl-7-(1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride; 2,4-Dichlorofluorobenzene; Methyl 3-Methoxyacrylate; Ethyl 3-ethoxyacrylate; 2,6-Dichlorofluorobenzene; 4-tert-Butylbenzoyl chloride; and 2, 4, 6-Trimethylbenzoyl chloride. The company was founded in 2011 and is based in Linhai, China.

Zhejiang Benli Technology Co., Ltd. Fundamentals Summary

How do Zhejiang Benli Technology's earnings and revenue compare to its market cap?
301065 fundamental statistics
Market capCN¥1.92b
Earnings (TTM)CN¥63.81m
Revenue (TTM)CN¥715.65m

30.1x

P/E Ratio

2.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
301065 income statement (TTM)
RevenueCN¥715.65m
Cost of RevenueCN¥593.06m
Gross ProfitCN¥122.59m
Other ExpensesCN¥58.79m
EarningsCN¥63.81m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 30, 2024

Earnings per share (EPS)0.62
Gross Margin17.13%
Net Profit Margin8.92%
Debt/Equity Ratio0.9%

How did 301065 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

17%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.